We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Mycelx Technologies Corporation | LSE:MYX | London | Ordinary Share | COM SHS USD0.025 (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 56.00 | 50.00 | 60.00 | 0.00 | 07:30:35 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Water Supply | 10.03M | -3.99M | -0.1736 | -3.23 | 12.87M |
From Apr 2019 to Apr 2024
TIDMMYX TIDMTTM
RNS Number : 3352V
MyCelx Technologies Corporation
13 April 2021
13 April 2021
MYCELX Technologies Corporation
("MYCELX" or the "Company") (AIM: MYX)
Grant of Options
The Company announces the grant of share options over the Company's common shares of US$0.025 each ("Common Shares") under the 2011 MYCELX Omnibus Performance Incentive Plan which was extended at the 2019 Annual Meeting (the "Plan").
Details of the awards to Directors and a PDMR on 12 April 2021 together with their current beneficial holding of Common Shares are presented in the following below:
Grant of Share Options to Chief Financial Officer
Hot Features
Premium
Name Number of share Exercise Total number Total number of
options granted price of share options share options
held following as % of current
this notification issued share capital
Kimberly Slayton 140,000 US$ 0.69* 270,000 1.39%
Ms. Slayton holds no Common Shares in the issued capital of the Company.
Grant of Share Options to President and Chief Science Officer
Name Number of share Exercise Total number Total number of
options granted price of share options share options
held following as % of current
this notification issued share capital
Haluk Alper 70,000 US$0.69* 124,339 0.64%
In addition, following this award, Mr. Alper continues to be interested in 1,262,046 Common Shares, representing 6.49 per cent of the present issued capital of the Company.
Grant of Share Options to Chief Executive Officer
Name Number of share Exercise Total number Total number of
options granted price of share options share options
held following as % of current
this notification issued share capital
Connie Mixon 210,000 US$0.69* 413,017 2.12%
In addition, following this award, Connie Mixon continues to be interested in 2,480,469 Common Shares, representing 12.76 per cent of the present issued capital of the Company.
The aggregate number of Common Shares held by Ms. Mixon also includes (a) 150,000 shares held by limited liability companies controlled by Ms. Mixon; and (b) 202,646 shares held by or on behalf of Ms. Mixon's children.
The above grants formed part of wider grants of, in aggregate, 769,000 options to employees across the Company, on the same date, representing 3.95% of the current issued share capital.
These share options granted on 12 April 2021 will vest as to one third equally on 12 April 2021, 12 April 2022 and 12 April 2023, and must be exercised prior to the tenth anniversary of the date of grant, subject to the restrictions on dealing under the Company's share dealing code.
Following the above grants, a total of 2,038,338 share options have been granted to directors and employees and are currently outstanding, representing 10.48% of the issued share capital of 19,443,750 Common Shares.
*Based on the closing mid-market price of the Company's Common Shares at 12 April 2021, and the closing US/GBP exchange rate at that date.
For further information please contact:
MYCELX Technologies Corporation Connie Mixon, CEO Tel: +1 888 306 6843 Kim Slayton, CFO Canaccord Genuity, Nominated Adviser Henry Fitzgerald-O'Connor Tel: + 44 20 7523 8000 Georgina McCooke Celicourt Mark Antelme Tel: +44 20 8434 2754 Jimmy Lea
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation (No. 596/2014).
Notification of transactions of persons discharging managerial responsibility or connected persons
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Connie Mixon
-------------------------- ---------------------------------------
2 Reason for the notification
-------------------------------------------------------------------
a) Position/status Director
-------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name MYCELX Technologies Corporation
-------------------------- ---------------------------------------
b) LEI 213800UJZINIK2VD1G48
-------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Common shares of US$0.025
type of instrument
Identification code USU624551078
-------------------------- ---------------------------------------
b) Nature of the transaction Grant of share option to Connie Mixon
under the MYCELX Omnibus Performance
Incentive Plan
-------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
US$0.69 210,000
----------
-------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume n/a
- Price n/a
-------------------------- ---------------------------------------
e) Date of the transaction 12/04/2021
-------------------------- ---------------------------------------
f) Place of the transaction Grant of the options occurred outside
a trading venue.
-------------------------- ---------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Kimberly Slayton
-------------------------- ---------------------------------------
2 Reason for the notification
-------------------------------------------------------------------
a) Position/status PDMR
-------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name MYCELX Technologies Corporation
-------------------------- ---------------------------------------
b) LEI 213800UJZINIK2VD1G48
-------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Common shares of US$0.025
type of instrument
USU624551078
Identification code
-------------------------- ---------------------------------------
b) Nature of the transaction Grant of share option to Kimberly
Slayton under the MYCELX Omnibus
Performance Incentive Plan
-------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
US$0.69 140,000
----------
-------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume n/a
- Price n/a
-------------------------- ---------------------------------------
e) Date of the transaction 12/04/2021
-------------------------- ---------------------------------------
f) Place of the transaction Grant of the options occurred outside
a trading venue.
-------------------------- ---------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Haluk Alper
-------------------------- ---------------------------------------
2 Reason for the notification
-------------------------------------------------------------------
a) Position/status Director
-------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name MYCELX Technologies Corporation
-------------------------- ---------------------------------------
b) LEI 213800UJZINIK2VD1G48
-------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Common shares of US$0.025
type of instrument
USU624551078
Identification code
-------------------------- ---------------------------------------
b) Nature of the transaction Grant of share option to Haluk Alper
under the MYCELX Omnibus Performance
Incentive Plan
-------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
US$0.69 70,000
----------
-------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume n/a
- Price n/a
-------------------------- ---------------------------------------
e) Date of the transaction 12/04/2021
-------------------------- ---------------------------------------
f) Place of the transaction Grant of the options occurred outside
a trading venue.
-------------------------- ---------------------------------------
Notes to Editors
Through its revolutionary oil-free water technology, MYCELX brings its customers material benefits in terms of performance enhancement, cost savings and significantly improved environmental footprints. Working beyond any ordinary filtration methods, MYCELX's proprietary technology achieves oil removal to less than one part per million. MYCELX supports leading international customers across the oil & gas value chain, as well as other industrial users. MYCELX also provides advanced air filtration technology for manufacturing and industrial facilities, effectively removing oil particles and biologicals to maintain continuous and safe air quality levels.
For more information, visit www.MYCELX.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFSFSSIVLIL
(END) Dow Jones Newswires
April 13, 2021 08:49 ET (12:49 GMT)
1 Year Mycelx Technologies Chart |
1 Month Mycelx Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
